July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Transforming diagnostics in rare ocular malignancies
Author Affiliations & Notes
  • Sarah E Coupland
    Molecular and Clinical Cancer Medicine, Univ of Liverpool, Liverpool, ENGLAND, United Kingdom
    Pathology, Royal Liverpool University Hospital, Liverpool, United Kingdom
  • Footnotes
    Commercial Relationships   Sarah Coupland, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 4767. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sarah E Coupland; Transforming diagnostics in rare ocular malignancies. Invest. Ophthalmol. Vis. Sci. 2019;60(9):4767.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Presentation Description : Molecular technologies have been developing at a rapid pace in diagnostic pathology, and have become affordable in most places, allowing for implementation in health care systems. These new molecular technologies have: a) enabled a better understanding of the pathogenesis of diseases; b) allowed for improved diagnostic procedures in ophthalmic pathology, particular in infection and eye cancers; c) aided prediction to response to therapy; and d) refined prognostication. In this presentation, examples of how molecular pathology is being applied in ophthalmological samples will be provided.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.